Recent CJEU decisions on SPCs have brought little clarity to the meaning of ‘product’, and a recent Advocate General opinion in Bayer CropScience AG threatens to muddy the waters even further, says Paul England.
There has been a considerable amount of activity in the Court of Justice of the European Union (CJEU) recently on the subject of supplementary protection certificates (SPCs). A number of rulings have come down, and others have been referred to the court. Some of these have concerned what ought to be regarded as one of the most simple elements of the legislation: what is meant by a ‘product’, as defined, for the purpose of being capable of protection by an SPC?
But this question has proved to be anything but simple. This is unfortunate, because if something qualifies as a ‘product’ then it is potentially capable of up to five years’ additional exclusivity protection when the patent that protects it expires.
The recent rulings from the CJEU on products have concerned SPC protection for medicinal products, under Regulation (EC) No 469/2009 (the medicinal SPC regulation). These have been controversial. The reason is that under earlier authorities it had been understood that a product, as the regulation itself stipulates, is restricted to an active ingredient or combination of active ingredients. As a result, products which are, for example, new salts of previously authorised active ingredients are not capable of SPC protection.
You need a subscription to continue reading this content.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
CJEU, SPCs, Bayer CropScience, Neurim, safeners